Watchlist Price Alert

Allogene Therapeutics Inc... (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.09

-0.02 (-1.80%)

At close: May 22, 2025, 3:59 PM

1.09

-0.46%

Pre-market: May 23, 2025, 06:17 AM EDT

Allogene Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	75.22M	83.16M	576.47M	809.48M	1.03B	588.86M	721.35M	n/a
Short-Term Investments	217.26M	365.54M	455.42M	283.99M	644.56M	355.41M	366.95M	n/a
Long-Term Investments	80.67M	3.65M	59.15M	370.18M	207.95M	63.21M	261.97M	n/a
Other Long-Term Assets	33.39M	16.9M	32.67M	-322.05M	14.62M	8.92M	1.54M	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	2.4M	3.11M	n/a
Inventory	n/a	n/a	-62.45M	-20.02M	-207.01M	-60.73M	-261.97M	n/a
Other Current Assets	10.91M	1.7M	11.5M	n/a	n/a	2.63M	n/a	n/a
Total Current Assets	303.39M	459.12M	528.82M	809.48M	845.13M	544.58M	467.98M	n/a
Property-Plant & Equipment	131.26M	163.18M	196.43M	181.02M	160.13M	100.94M	41.61M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	151K	754K	n/a
Total Long-Term Assets	245.32M	183.72M	288.25M	229.15M	382.7M	173.23M	305.87M	n/a
Total Assets	548.71M	642.84M	817.08M	1.04B	1.23B	717.8M	773.86M	n/a
Account Payables	5.39M	5.9M	13.89M	10.26M	10.39M	9.25M	12.34M	n/a
Deferred Revenue	n/a	86K	885K	423K	38.99M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	12.15M	11.66M	15.9M	18.59M	26.02M	7.76M	5.2M	n/a
Total Current Liabilities	35.52M	37.08M	54.52M	48.17M	94.32M	33.08M	29.46M	2K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	7.76M	5.18M	5.85M	4.13M	3.08M	4.35M	6.78M	n/a
Total Long-Term Liabilities	91.01M	93.53M	96.69M	74.05M	53.89M	55.7M	41.23M	n/a
Total Liabilities	126.53M	130.6M	151.21M	122.23M	148.21M	88.78M	70.69M	2K
Total Debt	90.76M	95.12M	95.12M	69.93M	53.78M	51.35M	34.46M	n/a
Common Stock	212K	169K	144K	142K	140K	124K	121K	26K
Retained Earnings	-1.82B	-1.56B	-1.24B	-903.35M	-646.34M	-396.12M	-211.53M	-23K
Comprehensive Income	-89K	-955K	-9.93M	-2.57M	268K	1.15M	306K	-5K
Shareholders Equity	422.18M	512.23M	665.87M	916.41M	1.08B	629.02M	703.16M	-2K
Total Investments	297.93M	369.19M	514.57M	654.17M	852.5M	418.62M	628.92M	n/a